Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Arthritis Research & Therapy
Published in: Arthritis Research & Therapy 1/2013

01-03-2013 | Review

IL-10-producing regulatory B cells (B10 cells) in autoimmune disease

Authors: Ioannis Kalampokis, Ayumi Yoshizaki, Thomas F Tedder

Published in: Arthritis Research & Therapy | Special Issue 1/2013

Login to get access

Abstract

B cell abnormalities contribute to the development and progress of autoimmune disease.Traditionally, the role of B cells in autoimmune disease was thought to be predominantly limited tothe production of autoantibodies. Nevertheless, in addition to autoantibody production, B cells haveother functions potentially relevant to autoimmunity. Such functions include antigen presentation toand activation of T cells, expression of co-stimulatory molecules and cytokine production. Recently,the ability of B cells to negatively regulate cellular immune responses and inflammation has beendescribed and the concept of regulatory B cells has emerged. A variety of cytokines produced byregulatory B cell subsets have been reported, with IL-10 being the most studied. In this review,this specific IL-10-producing subset of regulatory B cells has been labeled B10 cells to highlightthat the regulatory function of these rare B cells is mediated by IL-10, and to distinguish themfrom other B cell subsets that regulate immune responses through different mechanisms. B10 cells area functionally defined subset currently identified only by their competency to produce and secreteIL-10 following appropriate stimulation. Although B10 cells share surface markers with otherpreviously defined B cell subsets, currently there is no cell surface or intracellular phenotypicmarker or set of markers unique to B10 cells. The recent discovery of an effective way to expand B10cells ex vivo opens new horizons in the potential therapeutic applications of this rare Bcell subset. This review highlights the current knowledge on B10 cells and discusses their potentialas novel therapeutic agents in autoimmunity.
Literature
1.
Lipsky PE: Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity. Nat Immunol. 2001, 2: 764-766. 10.1038/ni0901-764.CrossRefPubMed
2.
3.
DiLillo DJ, Hamaguchi Y, Ueda Y, Yang K, Uchida J, Haas KM, Kelsoe G, Tedder TF: Maintenance of long-lived plasma cells and serological memory despite mature and memory B celldepletion during CD20 immunotherapy in mice. J Immunol. 2008, 180: 361-371.CrossRefPubMed
4.
Liu Y, Wu Y, Ramarathinam L, Guo Y, Huszar D, Trounstine M, Zhao M: Gene-targeted B-deficient mice reveal a critical role for B cells in the CD4 T cell response. Int Immunol. 1995, 7: 1353-1362. 10.1093/intimm/7.8.1353.CrossRefPubMed
5.
Linton PJ, Harbertson J, Bradley LM: A critical role for B cells in the development of memory CD4 cells. J Immunol. 2000, 165: 5558-5565.CrossRefPubMed
6.
Crawford A, Macleod M, Schumacher T, Corlett L, Gray D: Primary T cell expansion and differentiation in vivo requires antigen presentation by B cells. J Immunol. 2006, 176: 3498-3506.CrossRefPubMed
7.
Bouaziz JD, Yanaba K, Venturi GM, Wang Y, Tisch RM, Poe JC, Tedder TF: Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activationin mice. Proc Natl Acad Sci USA. 2007, 104: 20882-20887.CrossRef
8.
Homann D, Tishon A, Berger DP, Weigle WO, von Herrath MG, Oldstone MB: Evidence for an underlying CD4 helper and CD8 T cell defect in B cell-deficient mice: failure toclear persistent virus infection after adoptive immunotherapy with virus-specific memory cells fromμMT/μMT mice. J Virol. 1998, 72: 9208-9216.PubMedCentralPubMed
9.
Bergmann CC, Ramakrishna C, Kornacki M, Stohlman SA: Impaired T cell immunity in B cell-deficient mice following viral central nervous systeminfection. J Immunol. 2001, 167: 1575-1583.CrossRefPubMed
10.
O'Neill SK, Cao Y, Hamel KM, Doodes PD, Hutas G, Finnegan A: Expression of CD80/86 on B cells is essential for autoreactive T cell activation and thedevelopment of arthritis. J Immunol. 2007, 179: 5109-5116.CrossRefPubMed
11.
Linton PJ, Bautista B, Biederman E, Bradley ES, Harbertson J, Kondrack RM, Padrick RC, Bradley LM: Costimulation via OX40L expressed by B cells is sufficient to determine the extent of primary CD4cell expansion and Th2 cytokine secretion in vivo. J Exp Med. 2003, 197: 875-883. 10.1084/jem.20021290.PubMedCentralCrossRefPubMed
12.
Joao C, Ogle BM, Gay-Rabinstein C, Platt JL, Cascalho M: B cell-dependent TCR diversification. J Immunol. 2004, 172: 4709-4716.CrossRefPubMed
13.
AbuAttieh M, Rebrovich M, Wettstein PJ, Vuk-Pavlovic Z, Limper AH, Platt JL, Cascalho M: Fitness of cell-mediated immunity independent of repertoire diversity. J Immunol. 2007, 178: 2950-2960.CrossRefPubMed
14.
Moulin V, Andris F, Thielemans K, Maliszewski C, Urbain J, Moser M: B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 productionby DCs from B cell-deficient mice results in T helper cell type 1 deviation. J Exp Med. 2000, 192: 475-482. 10.1084/jem.192.4.475.PubMedCentralCrossRefPubMed
15.
16.
Golovkina TV, Shlomchik M, Hannum L, Chervonsky A: Organogenic role of B lymphocytes in mucosal immunity. Science. 1999, 286: 1965-1968. 10.1126/science.286.5446.1965.CrossRefPubMed
17.
Crowley MT, Reilly CR, Lo D: Influence of lymphocytes on the presence and organization of dendritic cell subsets in thespleen. J Immunol. 1999, 163: 4894-4900.PubMed
18.
Tumanov A, Kuprash D, Lagarkova M, Grivennikov S, Abe K, Shakhov A, Drutskaya L, Stewart C, Chervonsky A, Nedospasov S: Distinct role of surface lymphotoxin expressed by B cells in the organization of secondarylymphoid tissues. Immunity. 2002, 17: 239-250. 10.1016/S1074-7613(02)00397-7.CrossRefPubMed
19.
Gonzalez M, Mackay F, Browning JL, Kosco-Vilbois MH, Noelle RJ: The sequential role for lymphotoxin and B cells in the development of splenic follicles. J Exp Med. 1998, 187: 997-1007. 10.1084/jem.187.7.997.PubMedCentralCrossRefPubMed
20.
Liu Q, Liu Z, Rozo CT, Hamed HA, Alem F, Urban JF, Gause WC: The role of B cells in the development of CD4 effector T cells during a polarized Th2 immuneresponse. J Immunol. 2007, 179: 3821-3830.PubMedCentralCrossRefPubMed
21.
Wolf SD, Dittel BN, Hardardottir F, Janeway CA: Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med. 1996, 184: 2271-2278. 10.1084/jem.184.6.2271.PubMedCentralCrossRefPubMed
22.
Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM: B cells regulate autoimmunity by provision of IL-10. Nat Immunol. 2002, 3: 944-950.CrossRefPubMed
23.
Matsushita T, Yanaba K, Bouaziz J-D, Fujimoto M, Tedder TF: Regulatory B cells inhibit EAE initiation in mice while other B cells promote diseaseprogression. J Clin Invest. 2008, 118: 3420-3430.PubMedCentralPubMed
24.
Fillatreau S, Gray D, Anderton SM: Not always the bad guys: B cells as regulators of autoimmune pathology. Nat Rev Immunol. 2008, 8: 391-397. 10.1038/nri2315.CrossRefPubMed
25.
Mizoguchi A, Mizoguchi E, Takedatsu H, Blumberg RS, Bhan AK: Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subsetcharacterized by CD1d upregulation. Immunity. 2002, 16: 219-230. 10.1016/S1074-7613(02)00274-1.CrossRefPubMed
26.
27.
Mauri C, Ehrenstein MR: The 'short' history of regulatory B cells. Trends Immunol. 2008, 29: 34-40. 10.1016/j.it.2007.10.004.CrossRefPubMed
28.
29.
Bouaziz J-D, Yanaba K, Tedder TF: Regulatory B cells as inhibitors of immune responses and inflammation. Immunol Rev. 2008, 224: 201-214. 10.1111/j.1600-065X.2008.00661.x.CrossRefPubMed
30.
Yanaba K, Bouaziz J-D, Haas KM, Poe JC, Fujimoto M, Tedder TF: A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls Tcell-dependent inflammatory responses. Immunity. 2008, 28: 639-650. 10.1016/j.immuni.2008.03.017.CrossRefPubMed
31.
Mauri C, Bosma A: Immune regulatory function of B cells. Annu Rev Immunol. 2012, 30: 221-241. 10.1146/annurev-immunol-020711-074934.CrossRefPubMed
32.
DiLillo DJ, Matsushita T, Tedder TF: B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, andcancer. Ann N Y Acad Sci. 2010, 1183: 38-57. 10.1111/j.1749-6632.2009.05137.x.CrossRefPubMed
33.
Pistoia V: Production of cytokines by human B cells in health and disease. Immunol Today. 1997, 18: 343-350. 10.1016/S0167-5699(97)01080-3.CrossRefPubMed
34.
Ray A, Basu S, Williams CB, Salzman NH, Dittel BN: A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenanceof regulatory T cells via GITR ligand. J Immunol. 2012, 188: 3188-3198. 10.4049/jimmunol.1103354.PubMedCentralCrossRefPubMed
35.
Matsushita T, Tedder TF: Identifying regulatory B cells (B10 cells) that produce IL-10. Methods Mol Biol. 2011, 677: 99-111.CrossRefPubMed
36.
Yoshizaki A, Miyagaki T, Dilillo DJ, Matsushita T, Horikawa M, Kountikov EI, Spolski R, Poe JC, Leonard WJ, Tedder TF: Regulatory B cells control T cell autoimmunity through IL-21-dependent cognate interactions. Nature. 2012, 491: 264-268. 10.1038/nature11501.PubMedCentralCrossRefPubMed
37.
Yanaba K, Bouaziz JD, Matsushita T, Tsubata T, Tedder TF: The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigenreceptor diversity and TLR signals. J Immunol. 2009, 182: 7459-7472. 10.4049/jimmunol.0900270.PubMedCentralCrossRefPubMed
38.
Tedder TF, Poe JC, Haas KM: CD22: a multi-functional receptor that regulates B lymphocyte survival and signaltransduction. Adv Immunol. 2005, 88: 1-50.CrossRefPubMed
39.
Higuchi T, Aiba Y, Nomura T, Matsuda J, Mochida K, Suzuki M, Kikutani H, Honjo T, Nishioka K, Tsubata T: Cutting edge: ectopic expression of CD40 ligand on B cells induces lupus-like autoimmunedisease. J Immunol. 2002, 168: 9-12.CrossRefPubMed
40.
Poe JC, Smith S-H, Haas KM, Yanaba K, Tsubata T, Matsushita T, Tedder TF: Amplified B lymphocyte CD40 signaling drives regulatory B10 cell expansion in mice. PLoS One. 2011, 6: e22464-10.1371/journal.pone.0022464.PubMedCentralCrossRefPubMed
41.
Ding Q, Yeung M, Camirand G, Zeng Q, Akiba H, Yagita H, Chalasani G, Sayegh MH, Najafian N, Rothstein DM: Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1ligation to promote tolerance in mice. J Clin Invest. 2011, 121: 3645-3656. 10.1172/JCI46274.PubMedCentralCrossRefPubMed
42.
Wong SH, Barlow JL, Nabarro S, Fallon PG, McKenzie AN: Tim-1 is induced on germinal centre B cells through B cell receptor signalling but is notessential for the germinal centre response. Immunology. 2010, 131: 77-88.PubMedCentralPubMed
43.
Ma J, Usui Y, Takeda K, Harada N, Yagita H, Okumura K, Akiba H: TIM-1 signaling in B cells regulates antibody production. Biochem Biophys Res Commun. 2011, 406: 223-228. 10.1016/j.bbrc.2011.02.021.CrossRefPubMed
44.
Matsumoto M, Fujii Y, Baba A, Hikida M, Kurosaki T, Baba Y: The calcium sensors STIM1 and STIM2 control B cell regulatory function through interleukin-10production. Immunity. 2011, 34: 703-714. 10.1016/j.immuni.2011.03.016.CrossRefPubMed
45.
Miles K, Heaney J, Sibinska Z, Salter D, Savill J, Gray D, Gray M: A tolerogenic role for Toll-like receptor 9 is revealed by B cell interaction with DNA complexesexpressed on apoptotic cells. Proc Natl Acad Sci USA. 2012, 109: 887-892. 10.1073/pnas.1109173109.PubMedCentralCrossRefPubMed
46.
Gray M, Miles K, Salter D, Gray D, Savill J: Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory Bcells. Proc Natl Acad Sci USA. 2007, 104: 14080-14085. 10.1073/pnas.0700326104.PubMedCentralCrossRefPubMed
47.
Maseda D, Smith SH, DiLillo DJ, Bryant JM, Candando KM, Weaver CT, Tedder TF: Regulatory B10 cells differentiate into antibody-secreting cells after transient IL-10 productionin vivo. J Immunol. 2012, 188: 1036-1048. 10.4049/jimmunol.1102500.PubMedCentralCrossRefPubMed
48.
Iwata Y, Matsushita T, Horikawa M, DiLillo DJ, Yanaba K, Venturi GM, Szabolcs PM, Bernstein SH, Magro CM, Williams AD, Hall RP, St Clair EW, Tedder TF: Characterization of a rare IL-10-competent B cell subset in humans that parallels mouseregulatory B10 cells. Blood. 2011, 117: 530-541. 10.1182/blood-2010-07-294249.PubMedCentralCrossRefPubMed
49.
Bouaziz JD, Calbo S, Maho-Vaillant M, Saussine A, Bagot M, Bensussan A, Musette P: IL-10 produced by activated human B cells regulates CD4(+) T cell activation in vitro. Eur J Immunol. 2010, 40: 2686-2691. 10.1002/eji.201040673.CrossRefPubMed
50.
Serra P, Santamaria P: To 'B' regulated: B cells as members of the regulatory workforce. Trends Immunol. 2006, 27: 7-10. 10.1016/j.it.2005.11.003.CrossRefPubMed
51.
Blair PA, Norena LY, Flores-Borja F, Rawlings DJ, Isenberg DA, Ehrenstein MR, Mauri C: CD19+CD24hiCD38hi B cells exhibit regulatory capacity in healthyindividuals but are functionally impaired in systemic lupus erythematosus patients. Immunity. 2010, 32: 129-140. 10.1016/j.immuni.2009.11.009.CrossRefPubMed
52.
Yokoyama S, Staunton D, Fisher R, Amiot M, Fortin JJ, Thorley-Lawson DA: Expression of the Blast-1 activation/adhesion molecule and its identification as CD48. J Immunol. 1991, 146: 2192-2200.PubMed
53.
Tangye SG, Liu Y-J, Aversa G, Phillips JH, de Vries JE: Identification of functional human splenic memory B cells by expression of CD148 and CD27. J Exp Med. 1988, 188: 1691-1703.CrossRef
54.
Sanz I, Wei C, Lee FE-H, Anolik J: Phenotypic and functional heterogeneity of human memory B cells. Sem Immunol. 2008, 20: 67-82. 10.1016/j.smim.2007.12.006.CrossRef
55.
Klein U, Rajewsky K, Kuppers R: Human immunoglobulin (lg)M+IgD+ peripheral blood B cells expressing theCD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general markerfor somatically mutated (memory) B cells. J Exp Med. 1998, 188: 1679-1689. 10.1084/jem.188.9.1679.PubMedCentralCrossRefPubMed
56.
Agematsu K, Hokibara S, Nagumo H, Komiyama A: CD27: a memory B cell marker. Immunol Today. 2000, 21: 204-206. 10.1016/S0167-5699(00)01605-4.CrossRefPubMed
57.
Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC: Predominant autoantibody production by early human B cell precursors. Science. 2003, 301: 1374-1377. 10.1126/science.1086907.CrossRefPubMed
58.
Saraiva M, O'Garra A: The regulation of IL-10 production by immune cells. Nat Rev Immunol. 2010, 10: 170-181. 10.1038/nri2711.CrossRefPubMed
59.
Asadullah K, Sterry W, Volk HD: Interleukin-10 therapy -- review of a new approach. Pharmacol Rev. 2003, 55: 241-269. 10.1124/pr.55.2.4.CrossRefPubMed
60.
Matsushita T, Horikawa M, Iwata Y, Tedder TF: Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling EAEinitiation and late-phase immunopathogenesis. J Immunol. 2010, 185: 2240-2252. 10.4049/jimmunol.1001307.PubMedCentralCrossRefPubMed
61.
Yang M, Deng J, Liu Y, Ko KH, Wang X, Jiao Z, Wang S, Hua Z, Sun L, Srivastava G, Lau CS, Cao X, Lu L: IL-10-producing regulatory B10 cells ameliorate collagen-induced arthritis via suppressing Th17cell generation. Am J Pathol. 2012, 180: 2375-2385. 10.1016/j.ajpath.2012.03.010.CrossRefPubMed
62.
Gu Y, Yang J, Ouyang X, Liu W, Li H, Bromberg J, Chen SH, Mayer L, Unkeless JC, Xiong H: Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells. Eur J Immunol. 2008, 38: 1807-1813. 10.1002/eji.200838331.PubMedCentralCrossRefPubMed
63.
Mann MK, Maresz K, Shriver LP, Tan Y, Dittel BN: B cell regulation of CD4+CD25+ T regulatory cells and IL-10 via B7 isessential for recovery from experimental autoimmune encephalomyelitis. J Immunol. 2007, 178: 3447-3456.CrossRefPubMed
64.
Carter NA, Vasconcellos R, Rosser EC, Tulone C, Munoz-Suano A, Kamanaka M, Ehrenstein MR, Flavell RA, Mauri C: Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease andpresent with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J Immunol. 2011, 186: 5569-5579. 10.4049/jimmunol.1100284.CrossRefPubMed
65.
Sayi A, Kohler E, Toller IM, Flavell RA, Muller W, Roers A, Muller A: TLR-2- activated B cells suppress Helicobacter-induced preneoplastic gastric immunopathology byinducing T regulatory-1 cells. J Immunol. 2011, 186: 878-890. 10.4049/jimmunol.1002269.CrossRefPubMed
66.
Blair PA, Chavez-Rueda KA, Evans JG, Shlomchik MJ, Eddaoudi A, Isenberg DA, Ehrenstein MR, Mauri C: Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for thegeneration of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lprmice. J Immunol. 2009, 182: 3492-3502. 10.4049/jimmunol.0803052.PubMedCentralCrossRefPubMed
67.
Wei B, Velazquez P, Turovskaya O, Spricher K, Aranda R, Kronenberg M, Birnbaumer L, Braun J: Mesenteric B cells centrally inhibit CD4+ T cell colitis through interaction withregulatory T cell subsets. Proc Natl Acad Sci USA. 2005, 102: 2010-2015. 10.1073/pnas.0409449102.PubMedCentralCrossRefPubMed
68.
Amu S, Saunders SP, Kronenberg M, Mangan NE, Atzberger A, Fallon PG: Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive Tregulatory cells in a murine model. J Allergy Clin Immunol. 2010, 125: 1114-1124. 10.1016/j.jaci.2010.01.018.CrossRefPubMed
69.
Tadmor T, Zhang Y, Cho HM, Podack ER, Rosenblatt JD: The absence of B lymphocytes reduces the number and function of T-regulatory cells and enhancesthe anti-tumor response in a murine tumor model. Cancer Immunol Immunother. 2011, 60: 609-619. 10.1007/s00262-011-0972-z.CrossRefPubMed
70.
Sun JB, Flach CF, Czerkinsky C, Holmgren J: B lymphocytes promote expansion of regulatory T cells in oral tolerance: powerful induction byantigen coupled to cholera toxin B subunit. J Immunol. 2008, 181: 8278-8287.CrossRefPubMed
71.
Mangan NE, Fallon RE, Smith P, van Rooijen N, McKenzie AN, Fallon PG: Helminth infection protects mice from anaphylaxis via IL-10-producing B cells. J Immunol. 2004, 173: 6346-6356.CrossRefPubMed
72.
Ahangarani RR, Janssens W, VanderElst L, Carlier V, VandenDriessche T, Chuah M, Weynand B, Vanoirbeek JA, Jacquemin M, Saint-Remy JM: In vivo induction of type 1-like regulatory T cells using genetically modified B cells conferslong-term IL-10-dependent antigen-specific unresponsiveness. J Immunol. 2009, 183: 8232-8243. 10.4049/jimmunol.0901777.CrossRefPubMed
73.
Hoehlig K, Shen P, Lampropoulou V, Roch T, Malissen B, O'Connor R, Ries S, Hilgenberg E, Anderton SM, Fillatreau S: Activation of CD4+ Foxp3+ regulatory T cells proceeds normally in theabsence of B cells during EAE. Eur J Immunol. 2012, 42: 1164-1173. 10.1002/eji.201142242.CrossRefPubMed
74.
Amel Kashipaz MR, Huggins ML, Lanyon P, Robins A, Powell RJ, Todd I: Assessment of Be1 and Be2 cells in systemic lupus erythematosus indicates elevated interleukin-10producing CD5+ B cells. Lupus. 2003, 12: 356-363. 10.1191/0961203303lu338oa.CrossRefPubMed
75.
Llorente L, Richaud-Patin Y, Fior R, Alcocer-Varela J, Wijdenes J, Fourrier BM, Galanaud P, Emilie D: In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjogren's syndrome,and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity andautoimmunity. Arthritis Rheum. 1994, 37: 1647-1655. 10.1002/art.1780371114.CrossRefPubMed
76.
Pettinelli CB, McFarlin DE: Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitroactivation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2--T lymphocytes. J Immunol. 1981, 127: 1420-1423.PubMed
77.
Williams KC, Ulvestad E, Hickey WF: Immunology of multiple sclerosis. Clin Neurosci. 1994, 2: 229-245.PubMed
78.
Mizoguchi A, Mizoguchi E, Smith RN, Preffer FI, Bhan AK: Suppressive role of B cells in chronic colitis of T cell receptor α mutant mice. J Exp Med. 1997, 186: 1749-1756. 10.1084/jem.186.10.1749.PubMedCentralCrossRefPubMed
79.
Yanaba K, Yoshizaki A, Asano Y, Kadono T, Tedder TF, Sato S: IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model. Am J Pathol. 2011, 178: 735-743. 10.1016/j.ajpath.2010.10.022.PubMedCentralCrossRefPubMed
80.
Trentham DE, Townes AS, Kang AH: Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med. 1977, 146: 857-868. 10.1084/jem.146.3.857.CrossRefPubMed
81.
Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B: Immunisation against heterologous type II collagen induces arthritis in mice. Nature. 1980, 283: 666-668. 10.1038/283666a0.CrossRefPubMed
82.
Wordsworth BP, Lanchbury JS, Sakkas LI, Welsh KI, Panayi GS, Bell JI: HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the majorsusceptibility locus within the HLA class II region. Proc Natl Acad Sci USA. 1989, 86: 10049-10053. 10.1073/pnas.86.24.10049.PubMedCentralCrossRefPubMed
83.
Brunsberg U, Gustafsson K, Jansson L, Michaelsson E, Ahrlund-Richter L, Pettersson S, Mattsson R, Holmdahl R: Expression of a transgenic class II Ab gene confers susceptibility to collagen-inducedarthritis. Eur J Immunol. 1994, 24: 1698-1702. 10.1002/eji.1830240736.CrossRefPubMed
84.
Yanaba K, Hamaguchi Y, Venturi GM, Steeber DA, St.Clair EW, Tedder TF: B cell depletion delays collagen-induced arthritis in mice: arthritis induction requires synergybetween humoral and cell-mediated immunity. J Immunol. 2007, 179: 1369-1380.CrossRefPubMed
85.
Mauri C, Gray D, Mushtaq N, Londei M: Prevention of arthritis by interleukin 10-producing B cells. J Exp Med. 2003, 197: 489-501. 10.1084/jem.20021293.PubMedCentralCrossRefPubMed
86.
Evans JG, Chavez-Rueda KA, Eddaoudi A, Meyer-Bahlburg A, Rawlings DJ, Ehrenste in MR, Mauri C: Novel suppressive function of transitional 2B cells in experimental arthritis. J Immunol. 2007, 178: 7868-7878.CrossRefPubMed
87.
Haas KM, Watanabe R, Matsushita T, Nakashima H, Ishiura N, Okochi H, Fujimoto M, Tedder TF: Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1mice. J Immunol. 2010, 184: 4789-4800. 10.4049/jimmunol.0902391.PubMedCentralCrossRefPubMed
88.
Watanabe R, Ishiura N, Nakashima H, Kuwano Y, Okochi H, Tamaki K, Sato S, Tedder TF, Fujimoto M: Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 celldeficiency exacerbates systemic autoimmunity. J Immunol. 2010, 184: 4801-4809. 10.4049/jimmunol.0902385.PubMedCentralCrossRefPubMed
89.
Teichmann LL, Kashgarian M, Weaver CT, Roers A, Muller W, Shlomchik MJ: B cell -derived IL-10 does not regulate spontaneous systemic autoimmunity in MRL.Fas(lpr)mice. J Immunol. 2012, 188: 678-685. 10.4049/jimmunol.1102456.PubMedCentralCrossRefPubMed
90.
Anderson MS, Bluestone JA: The NOD mouse: a model of immune dysregulation. Ann u Rev Immunol. 2005, 23: 447-485. 10.1146/annurev.immunol.23.021704.115643.CrossRef
91.
Xiu Y, Wong CP, Hamaguchi Y, Wang Y, Pop S, Tisch RM, Tedder TF: B lymphocytes depletion by CD20 monoclonal antibody prevents diabetes in NOD mice despiteisotype-specific differences in FcγR effector functions. J Immunol. 2008, 180: 2863-2875.CrossRefPubMed
92.
Hussain S, Delovitch TL: Intravenous transfusion of BCR-activated B cells protects NOD mice from type 1 diabetes in anIL-10-dependent manner. J Immunol. 2007, 179: 7225-7232.CrossRefPubMed
93.
Tian J, Zekzer D, Hanssen L, Lu Y, Olcott A, Kaufman DL: Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetesin nonobese diabetic mice. J Immunol. 2001, 167: 1081-1089.CrossRefPubMed
94.
Vonderheide RH, Flaherty KT, Khalil M, Stumacher MS, Bajor DL, Hutnick NA, Sullivan P, Mahany JJ, Gallagher M, Kramer A, Green SJ, O'Dwyer PJ, Running KL, Huhn RD, Antonia SJ: Clinical activity and immune modulation in cancer patients treated with CP-870,893, a novel CD40agonist monoclonal antibody. J Clin Oncol. 2007, 25: 876-883. 10.1200/JCO.2006.08.3311.CrossRefPubMed
95.
Calderon-Gomez E, Lampropoulou V, Shen P, Neves P, Roch T, Stervbo U, Rutz S, Kuhl AA, Heppner FL, Loddenkemper C, Anderton SM, Kanellopoulos JM, Charneau P, Fillatreau S: Reprogrammed quiescent B cells provide an effective cellular therapy against chronic experimentalautoimmune encephalomyelitis. Eur J Immunol. 2011, 41: 1696-1708. 10.1002/eji.201041041.PubMedCentralCrossRefPubMed
Metadata
Title
IL-10-producing regulatory B cells (B10 cells) in autoimmune disease
Authors
Ioannis Kalampokis
Ayumi Yoshizaki
Thomas F Tedder
Publication date
01-03-2013
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue Special Issue 1/2013
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar3907

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24 to hear Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits